# Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)

> **NCT02999022** · PHASE2 · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 160 (estimated)

## Conditions studied

- Fractures

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Lactose Placebo

## Key facts

- **NCT ID:** NCT02999022
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-21
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02999022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02999022, "Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02999022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*